---
title: Improve balance using wearable technology
nct_id: NCT05680597
phase: NA
status: RECRUITING
sponsor: Oregon Health and Science University
study_type: INTERVENTIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT05680597"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT05680597"
last_fetched: "2026-05-10T14:06:06.616Z"
source: "Parkinson's Pathways (curated)"
---
# Improve balance using wearable technology

**Goal (in five words):** Improve balance using wearable technology

**Official Title:** Balance Tele-rehabilitation With Wearable Technology for Older Adults With Parkinson's Disease

**Trial ID:** [NCT05680597](https://clinicaltrials.gov/study/NCT05680597)

## Key Facts

- **Phase:** NA
- **Status:** RECRUITING
- **Study Type:** INTERVENTIONAL
- **Sponsor:** Oregon Health and Science University
- **Target Enrollment:** 80 participants
- **Start Date:** 2022-09-19
- **Completion Date:** 2027-06
- **Conditions:** Parkinson Disease
- **Interventions:** Balance Tele-Rehabilitation Agility Boot Camp (ABC)
- **Intervention Types:** OTHER

## Summary For Families

The trial is testing whether a remote, wearable-guided balance and agility program can improve balance and walking and reduce fall risk in older adults with Parkinson's. Participants do the Agility Boot Camp (ABC) exercises via tele-rehabilitation about three times a week for four weeks while wearable sensors track sway, steps, and movement to give objective feedback and measure changes; because it is an exercise intervention it does not change how levodopa works, and participants are asked to keep their Parkinson's medications stable during the study. They are enrolling people 55 to 85 years old with idiopathic, levodopa-responsive Parkinson's in Hoehn and Yahr stages I to III who can follow directions and participate in exercise, are not frequent fallers, have no major medical or cognitive barriers, and can stand and walk without an assistive device.

## Eligibility

- **Minimum age:** 55 Years
- **Maximum age:** 85 Years
- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

1. Diagnosis of idiopathic PD from movement disorders neurologist with the United Kingdom Brain Bank criteria of bradykinesia and one or more of the following - rest tremor, rigidity, and balance problems not from visual, vestibular, cerebellar or proprioceptive conditions
2. responsive to levodopa (self-reported)
3. Hoehn \& Yahr stages I-III;
4. ages 55-85 years old
5. ability to follow directions in order to participate in testing procedures and exercise classes
6. free of any medical conditions or medication that contraindicates participation in an exercise program
7. willing and able to participate in rehabilitation intervention approximately 3x/week for 4 weeks while also refraining from making changes to medications (as reasonable) or to other exercise programs during the study period.

Exclusion Criteria:

1. Major musculoskeletal or neurological disorders, structural brain disease, epilepsy, acute illness or health history, other than PD, significantly affecting gait and balance (i.e., musculoskeletal disorder, vestibular problem, head injury, stroke, cardiac disease, etc.)
2. no medical condition that precludes exercise
3. cognitive inability to participate in an exercise program, such as MoCA score less than or equal to 19, prior diagnosis of dementia or inability to follow directions
4. recurrent fallers, defined as those who fall more than 3 times a week (from patient and caregiver recollection)
5. excessive use of alcohol or recreational drugs
6. recent change in medication
7. inability to stand and walk for ISAW without an assistive device.
```

## Locations (1)

- Oregon Health Science University, Portland, Oregon, United States _(45.5234, -122.6762)_
  - Laurie King — (CONTACT) — kingla@ohsu.edu
  - Ruby Larisch — (CONTACT) — Larisch@ohsu.edu

## Central Contacts

- Laurie King, PhD — (CONTACT) — 503-418-2602 — kingla@ohsu.edu
- Martina Mancini, PhD — (CONTACT) — 503-418-2600 — mancinim@ohsu.edu

---

*Canonical: https://parkinsonspathways.com/trial/NCT05680597*  
*HTML version: https://parkinsonspathways.com/trial/NCT05680597*  
*Source data: https://clinicaltrials.gov/study/NCT05680597*